SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457612-22-000073
Filing Date
2022-06-03
Accepted
2022-06-03 16:11:27
Documents
1
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165428706230667.html 4  
1 FORM 4 wf-form4_165428706230667.xml 4 3478
  Complete submission text file 0001457612-22-000073.txt   4965
Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Clark William D (Reporting) CIK: 0001355415 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 22994486

Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 6178768191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)